{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:12:51Z","timestamp":1788685971607,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451\\u201303\\u2013137\/2025\\u201303\/200125"],"award-info":[{"award-number":["451\\u201303\\u2013137\/2025\\u201303\/200125"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451\\u201303\\u2013136\/2025\\u201303\/200125 & 451\\u201303\\u2013137\/2025\\u201303\/200134"],"award-info":[{"award-number":["451\\u201303\\u2013136\/2025\\u201303\/200125 & 451\\u201303\\u2013137\/2025\\u201303\/200134"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["KK.01.1.1.02.0007"],"award-info":[{"award-number":["KK.01.1.1.02.0007"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["533\\u201303\\u201323\\u20130006"],"award-info":[{"award-number":["533\\u201303\\u201323\\u20130006"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["643\\u201302\/23\\u201301\/00016"],"award-info":[{"award-number":["643\\u201302\/23\\u201301\/00016"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jsbmb.2026.106950","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:49:20Z","timestamp":1769874560000},"page":"106950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting cholinesterases with steroid hormone derivatives: Insights from In Vitro assays and molecular modeling"],"prefix":"10.1016","volume":"258","author":[{"given":"Jovana J.","family":"Ajdukovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mato\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Bosak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Strahinja","family":"Kova\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica Karad\u017ei\u0107","family":"Banjac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8045-3568","authenticated-orcid":false,"given":"Ivana Z.","family":"Kuzminac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Nikoli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina P.","family":"Savi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2026.106950_bib1","unstructured":"\u3008https:\/\/www.alzint.org\/about\/dementia-facts-figures\/dementia-statistics\/\u3009 (accessed 22.01.2026.)."},{"key":"10.1016\/j.jsbmb.2026.106950_bib2","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1080\/17568919.2025.2559573","article-title":"Pyrrolidine-based hybrid compounds: design, synthesis, in vitro and in vivo pharmacological properties and molecular docking studies","volume":"17","author":"Ta\u015f","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2018.12.006","article-title":"Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies","volume":"174","author":"Sharma","year":"2019","journal-title":"Prog. NeuroBiol."},{"key":"10.1016\/j.jsbmb.2026.106950_bib4","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2174\/0929867323666161213101126","article-title":"Alzheimer's dis-ease: a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment","volume":"25","author":"dos Santos Pican\u00e7oa","year":"2018","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110491","article-title":"A new series of naphthyl-thiosemicarbazone and thio\/carbohydrazone derivatives: synthesis, spectroscopic elucidation, dual enzyme inhibition targeting carbonic anhydrase\/ acetylcholinesterase and molecular docking studies","volume":"771","author":"Yakan","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jsbmb.2026.106950_bib6","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s11696-025-03947-3","article-title":"Imidazo[1,2-a]pyridine mannich bases: synthesis, anticholinesterase evaluation, and in silico studies","volume":"79","author":"Kuzu","year":"2025","journal-title":"Chem. Pap."},{"key":"10.1016\/j.jsbmb.2026.106950_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, aducanumab, and gantenerumab - binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for alzheimer's disease","volume":"20","author":"S\u00f6derberg","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jsbmb.2026.106950_bib8","doi-asserted-by":"crossref","first-page":"n3127","DOI":"10.1136\/bmj.n3127","article-title":"Aducanumab: European agency rejects Alzheimer's drug over efficacy and safety concerns","author":"Mahase","year":"2021","journal-title":"BMJ 375"},{"key":"10.1016\/j.jsbmb.2026.106950_bib9","series-title":"Butyrylcholinesterase, its function and inhibitors","first-page":"1","article-title":"Butyrylcholinesterase: its role in brain function","author":"Giacobini","year":"2003"},{"key":"10.1016\/j.jsbmb.2026.106950_bib10","series-title":"In Cholinesterase\u2019s and cholinesterase inhibitors","first-page":"103","article-title":"Mechanism of action of cholinesterase inhibitors","author":"Reiner","year":"2000"},{"key":"10.1016\/j.jsbmb.2026.106950_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pbiomolbio.2020.12.001","article-title":"The multiple biological roles of the cholinesterases","volume":"162","author":"Silman","year":"2021","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106950_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/mi13020287","article-title":"Acetylcholinesterase activity influenced by lipid membrane area and surface acoustic waves","volume":"13","author":"Schnitzler","year":"2022","journal-title":"Micromachines"},{"key":"10.1016\/j.jsbmb.2026.106950_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2022.02.006","article-title":"Butyrylcholinesterase in SH-SY5Y human neuroblastoma cells","volume":"90","author":"Onder","year":"2022","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jsbmb.2026.106950_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2026.106950_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer`s disease therapy","author":"Greig","year":"2002","journal-title":"Int Psychogeritar 14"},{"key":"10.1016\/j.jsbmb.2026.106950_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1389557023406638","article-title":"Cholinergic drugs in pharmacotherapy of alzheimers disease","volume":"2","author":"Camps","year":"2002","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib17","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2026.106950_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112556","article-title":"The biological activities of butyrylcholinesterase inhibitors","volume":"146","author":"Zhou","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.jsbmb.2026.106950_bib19","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease","volume":"271","author":"Watkins","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jsbmb.2026.106950_bib20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acsbiomedchemau.1c00071","article-title":"A comprehensive review on steroidal bioconjugates as promising leads in drug discovery","volume":"2","author":"Bansal","year":"2022","journal-title":"ACS Bio Med. Chem. Au"},{"key":"10.1016\/j.jsbmb.2026.106950_bib21","series-title":"Molecular Structure and Biological Activity of Steroids","author":"Bohl","year":"1992"},{"key":"10.1016\/j.jsbmb.2026.106950_bib22","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1021\/cr4002935","article-title":"Man-made cytotoxic steroids: exemplary agents for cancer therapy","volume":"114","author":"Bansal","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jsbmb.2026.106950_bib23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2174\/1568026623666230126162419","article-title":"Steroid and triterpenoid compounds with antiparasitic properties (Review Article)","volume":"23","author":"Kuzminac","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib24","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3390\/pharmaceutics16111401","article-title":"Abiraterone and galeterone, powerful tools against prostate cancer: present and perspective","volume":"16","author":"Kuzminac","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jsbmb.2026.106950_bib25","article-title":"Selectivity, stability, and pharmacokinetic profiling of Spongia-derived steroids targeting AChE and BuChE for Alzheimer\u2019s therapy","volume":"224","author":"Sampaio de Sousa","year":"2025","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2026.106950_bib26","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/biom12101430","article-title":"Isolation, in vitro and in silico anti-alzheimer and anti-inflammatory studies on phytosteroids from aerial parts of Fragaria \u00d7 ananassa Duch","volume":"12","author":"Mahnashi","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jsbmb.2026.106950_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/13880209.2015.1028078","article-title":"Compounds from Sedum caeruleum with antioxidant, anticholinesterase, and antibacterial activities","volume":"54","author":"Bensouici","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jsbmb.2026.106950_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jep.2016.06.013","article-title":"BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides","volume":"190","author":"Choi","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jsbmb.2026.106950_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmech.2017.06.007","article-title":"Isosteroidal alkaloids as potent dual-binding site inhibitors of both acetylcholinesterase and butyrylcholinesterase from the bulbs of Fritillaria walujewii","volume":"137","author":"Liu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2174\/092986708784310422","article-title":"Natural Products and their Derivatives as Cholinesterase Inhibitors in the Treatment of Neurodegenerative Disorders: An Update","volume":"15","author":"Loizzo","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106194","article-title":"Ring-fused 3\u03b2-acetoxyandrost-5-enes as novel neuroprotective agents with cholinesterase inhibitory properties","volume":"225","author":"Gonzalez","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106950_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104893","article-title":"Design, synthesis and evaluation of cholinesterase hybrid inhibitors using a natural steroidal alkaloid as precursor","volume":"111","author":"Borioni","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.steroids.2013.08.003","article-title":"Synthesis and acetylcholinesterase inhibitory activity of polyhydroxylated sulfated steroids: Structure\/activity studies","volume":"78","author":"Richmond","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2026.106950_bib34","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1134\/S106816202403021X","article-title":"Synthesis optimization, in silico and in vitro testing of D-homo lactone estra-1,3,5-triene derivatives","volume":"50","author":"Kuzminac","year":"2024","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0039-128X(01)00096-4","article-title":"New D-modified androstane derivatives as aromatase inhibitors","volume":"66","author":"Penov Ga\u0161i","year":"2001","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2026.106950_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bmc.2014.12.069","article-title":"Synthesis and anticancer cell potential of steroidal 16,17-seco-16,17a-dinitriles: Identification of a selective inhibitor of hormone-independent breast cancer cells","volume":"23","author":"Nikoli\u0107","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11224-016-0815-9","article-title":"Structural analysis and antitumor potential of novel 5,6-disubstituted-17a-homo-17-oxa-androstane derivatives","volume":"28","author":"Kuzminac","year":"2017","journal-title":"Struct. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106362","article-title":"Novel D-modified heterocyclic androstane derivatives as potential anticancer agents: Synthesis, characterization, in vitro and in silico studies","volume":"233","author":"\u0160esti\u0107","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106950_bib39","first-page":"675","article-title":"The chemical transformation of 3\u03b2,17\u03b2-dihydroxy-16-oximino-5-androstene","volume":"31","author":"Penov-Ga\u0161i","year":"2000","journal-title":"Acta Period. Technol."},{"key":"10.1016\/j.jsbmb.2026.106950_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.steroids.2006.10.002","article-title":"Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives","volume":"72","author":"Ga\u0161i","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2026.106950_bib41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.colsurfb.2016.09.041","article-title":"Selective anticancer activity of hydroxyapatite\/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor","volume":"148","author":"Ignjatovi\u0107","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jsbmb.2026.106950_bib42","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1016\/j.tetlet.2009.04.107","article-title":"An intramolecular one-pot synthesis of steroidal triazoles via 1,3-dipolar cycloadditions of in situ generated diazo compounds","volume":"50","author":"Saka\u010d","year":"2009","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jsbmb.2026.106950_bib43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2026.106950_bib44","first-page":"173","article-title":"Inhibition of human blood acetylcholinesterase and butyrylcholinesterase by ethopropazine","volume":"74","author":"Simeon-Rudolf","year":"2001","journal-title":"Croat. Chem. Acta"},{"key":"10.1016\/j.jsbmb.2026.106950_bib45","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jsbmb.2026.106950_bib46","doi-asserted-by":"crossref","first-page":"W324","DOI":"10.1093\/nar\/gkae300","article-title":"SwissDock 2024: major enhancements for small-molecule docking with attracting cavities and AutoDock Vina","volume":"52","author":"Bugnon","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsbmb.2026.106950_bib47","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jsbmb.2026.106950_bib48","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acs.jmedchem.0c01863","article-title":"Kinetics-driven drug design strategy for next-generation acetylcholinesterase inhibitors to clinical candidate","volume":"64","author":"Zhou","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib49","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1021\/acs.jmedchem.0c01775","article-title":"Discovery of a potent dual inhibitor of acetylcholinesterase and butyrylcholinesterase with antioxidant activity that alleviates alzheimer-like pathology in Old APP\/PS1 mice","volume":"64","author":"Viayna","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106950_bib50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13321-019-0362-7","article-title":"DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism","volume":"11","author":"Bell","year":"2019","journal-title":"J. Chemin.."},{"key":"10.1016\/j.jsbmb.2026.106950_bib51","series-title":"its function and inhibitors, Ezio Giacobini","article-title":"Butyrylcholinesterase: its selective inhibition and relevance to Alzheimer\u2019s disease therapy, in Butyrylcholinesterase","author":"Greig","year":"2003"}],"updated-by":[{"DOI":"10.1016\/j.jsbmb.2026.107099","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000}},{"DOI":"10.1016\/j.jsbmb.2026.107099","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026000166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026000166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:07:29Z","timestamp":1774004849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076026000166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":51,"alternative-id":["S0960076026000166"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.106950","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting cholinesterases with steroid hormone derivatives: Insights from In Vitro assays and molecular modeling","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.106950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106950"}}